Podcast Triple therapy talks

Produced by IZIDOK in collaboration with Bayer, this podcast series delves into the management of metastatic Hormone-Sensitive Prostate Cancer (mHSPC) with triple therapy. Hosted by Dr. Guillaume Grisay, the series spans three episodes featuring discussions with medical oncologists Dr. Michiel Strijbos and Professor Christoph Vulsteke, and urologist Professor Bertrand Tombal. The conversations explore patient selection, the administration of triple therapy, its tolerance, and its impact on quality of life and disease outcomes. The series highlights the evolving treatment landscape for mHSPC and the potential for triple therapy to improve patients’ outcomes significantly. It calls for a multidisciplinary approach to patient care, underscoring the need for ongoing research and dialogue within the medical community to optimize treatment strategies.

Date of approval: 07/06/2024 - PP-NUB-BE-0204-1’

This podcast was created and is intended for healthcare professionals only. It may only be shared with healthcare professionals and is intended for informational purposes only.  The content of this podcast in no way constitutes a physician's recommendation and should not be construed as medical advice on any matter. Any statements made in the presentation by the speakers reflect their personal views, experience or opinions. The reproduction, distribution, communication to the public and/or modification of the content of the podcast are not permitted.